Skip to main content
Premium Trial:

Request an Annual Quote

Virtual Reality Exec Named GeneFormatics President

Premium

SAN DIEGO--GeneFormatics, an early-stage functional genomics and datamining company here, announced that John Chiplin has been appointed president and CEO. Chiplin last served as CEO of Superscape, a publicly traded, European, virtual reality technology company, where he negotiated partnerships with Microsoft, Intel, and Lego. Previously, Chiplin spent eight years in sales and marketing positions at Biosym Technologies, a supplier of molecular CAD software. Contended Chiplin, "Datamining has to be a top priority for any organization trying to make sense of the genome, and GeneFormatics offers the most advanced technology to effectively address this problem."

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.